Garrison Point Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Garrison Point Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	30,091 -2,297	-7%	-$117K	0.6%	47
2026 Q1	$1.73M	Sell	32,388 -100	-0.3%	-$5.87K	0.79%	33
2025 Q4	$2.02M	Buy	32,488 +118	+0.4%	+$7.29K	0.89%	26
2025 Q3	$1.94M	Sell	32,370 -401	-1%	-$24.5K	0.82%	29
2025 Q2	$2.05M	Sell	32,771 -750	-2%	-$45.1K	0.94%	26
2025 Q1	$2.02M	Sell	33,521 -480	-1%	-$29.8K	0.98%	23
2024 Q4	$1.98M	Buy	34,001 +360	+1%	+$21.4K	0.94%	24
2024 Q3	$1.99M	Buy	33,641 +506	+2%	+$28.9K	1.23%	20
2024 Q2	$1.86M	Buy	33,135 +64	+0.2%	+$3.58K	1.23%	20
2024 Q1	$1.94M	Sell	33,071 -10	-0%	-$565	1.25%	20
2023 Q4	$1.79M	Buy	33,081 +200	+0.6%	+$9.77K	1.26%	21
2023 Q3	$1.59M	Sell	32,881 -414	-1%	-$22K	1.23%	21
2023 Q2	$1.88M	Sell	33,295 -83	-0.2%	-$4.57K	1.35%	17
2023 Q1	$1.8M	Buy	33,378 +15	+0%	+$799	1.35%	17
2022 Q4	$1.75M	Sell	33,363 -92	-0.3%	-$4.67K	1.43%	18
2022 Q3	$1.58M	Buy	33,455 +186	+0.6%	+$9.65K	1.41%	19
2022 Q2	$1.68M	Sell	33,269 -30	-0.1%	-$1.64K	1.39%	20
2022 Q1	$2.03M	Buy	33,299 +124	+0.4%	+$7.39K	1.42%	17
2021 Q4	$2.19M	Buy	33,175 +245	+0.7%	+$15.7K	1.45%	17
2021 Q3	$2.07M	Sell	32,930 -100	-0.3%	-$6.38K	1.5%	17
2021 Q2	$1.99M	Hold	33,030	–	–	1.43%	15
2021 Q1	$1.82M	Sell	33,030 -150	-0.5%	-$8.32K	1.41%	18
2020 Q4	$1.81M	Sell	33,180 -750	-2%	-$39.2K	1.46%	17
2020 Q3	$1.69M	Hold	33,930	–	–	1.54%	17
2020 Q2	$1.5M	Sell	33,930 -240	-0.7%	-$10.3K	1.48%	18
2020 Q1	$1.28M	Sell	34,170 -1,710	-5%	-$72K	1.57%	19
2019 Q4	$1.58M	Buy	35,880 +180	+0.5%	+$7.57K	1.45%	21
2019 Q3	$1.47M	Buy	35,700 +180	+0.5%	+$7.37K	1.46%	20
2019 Q2	$1.43M	Buy	35,520 +810	+2%	+$30.7K	1.43%	24
2019 Q1	$1.34M	Buy	34,710 +690	+2%	+$25.1K	1.4%	23
2018 Q4	$1.13M	Buy	+34,020	New	+$1.18M	1.4%	20

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Garrison Point Advisors's IHI Position: Q2 2026 in Review

Garrison Point Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 7.1% in Q2 2026, selling an estimated $117K and leaving 30,091 shares worth $1.49M. The position accounts for 0.6% of the portfolio, ranked #47.

Garrison Point Advisors first reported a position in IHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.19M in Q4 2021. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Garrison Point Advisors held 30,091 shares of iShares US Medical Devices ETF worth $1.49M as of Q2 2026.
Garrison Point Advisors sold 2,297 iShares US Medical Devices ETF shares in Q2 2026, an estimated $117K.
iShares US Medical Devices ETF made up 0.6% of Garrison Point Advisors's portfolio in Q2 2026, its #47 holding.
Garrison Point Advisors first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 31 quarters since.
Garrison Point Advisors's iShares US Medical Devices ETF position peaked at $2.19M in Q4 2021.
502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.